Added to YB: 2026-07-21
Pitch date: 2026-07-18
ELV [bullish]
Elevance Health, Inc.
+1.54%
current return
Author Info
No bio for this author
Company Info
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.
Market Cap
$80.9B
Pitch Price
$376.42
Price Target
N/A
Dividend
1.84%
EV/EBITDA
12.03
P/E
16.60
EV/Sales
0.51
Sector
Health Care Providers and Services
Category
turnaround
ELV/UNH 2Q26
ELV (added to position): Bought more at $370 (vs $290-345 prior). Health insurer at underwriting cycle nadir; costs outran pricing in 2024-25, compressing margins. 2Q26: cost trends flattening/decelerating; Medicaid -1.75% vs 2%+ normal, MA 2% vs 3-5%, holding profits down >$2B/yr. Fee-based commercial protects downside. Cycle historically turns in ~5yrs. Carelon underpenetrated (28% of spend vs Optum 60%)—huge vertical integration runway. 5+yr thesis; ELV reprices slower than UNH (more Medicaid).
Read full article (11 min)